抗體雞尾酒療法市場：按類型、適應症、分銷管道和地區分類

Antibody Cocktails Market, By Type, By Indication, By Distribution Channel, By Geography

出版日期: 2026年03月09日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，抗體雞尾酒療法市場規模將達22億美元，到2033年將達到73億美元。預計從2026年到2033年，該市場將以17.7%的複合年成長率成長。

分析範圍		分析詳情
基準年	2025	市場規模（2026 年）	22億美元
效能數據	2020-2024	預測期	2026-2033
預測期（2026-2033 年）複合年成長率	17.70%	預計金額（2033 年）	73億美元

抗體（又稱免疫球蛋白）是人體免疫系統針對稱為抗原的外來物質所產生的防禦性蛋白質。抗原包括多種物質，如病原體、昆蟲毒液、細菌和病毒。抗體雞尾酒療法基本上是兩種不同抗體的組合。採用雞尾酒療法組合兩種抗體的目的是為了最大限度地減少病毒變異導致的免疫逃脫。

市場動態

預計在預測期內，市場主要企業擴大採用非內生性成長策略，例如建立合作夥伴關係和簽署協議，將推動市場成長。例如，2021年5月，跨國醫療保健公司羅氏（F. Hoffmann-La Roche）與跨國製藥公司西普拉（Cipla）達成策略合作。根據合作協議，羅氏將把其抗體雞尾酒療法（卡西利單抗和伊維單抗）進口到印度，並透過西普拉的分銷網路在印度進行銷售和分銷。

此外，2020年8月，跨國醫療保健公司羅氏（F. Hoffmann-La Roche）和生物技術公司再生元製藥（Regeneron Pharmaceuticals）宣布達成協議，共同開發、生產和供應再生元臨床實驗的抗病毒抗體雞尾酒療法REGN-COV2，以服務全球患者。此次合作預計將使REGN-COV2的供應量至少提升至目前產能的3.5倍，並具有進一步擴大的潛力。根據協議，再生元將負責REGN-COV2在美國的經銷，而羅氏將負責美國以外地區的經銷。

本報告的主要特點

本報告指出了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本文根據以下參數，介紹了全球抗體雞尾酒療法市場主要企業的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、產品線更新、市場擴張和行銷策略做出明智的決策。
《全球抗體雞尾酒市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過分析全球抗體雞尾酒療法市場中使用的各種策略矩陣來促進決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太地區
中東
- 波灣合作理事會（GCC）國家
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

Cipla Inc.
F. Hoffmann-La Roche Ltd
Regeneron Pharmaceuticals Inc.
Zydus Cadila
AstraZeneca
Aridis Pharmaceuticals Inc.
AstraZene Immunome Inc.
Celltrion Healthcare Co., Ltd.
Eli Lilly and Company

第9章

分析方法
關於 Coherent Market Insights

簡介目錄

Product Code: CMI4950

Antibody Cocktails Market is estimated to be valued at USD 2.2 Bn in 2026 and is expected to reach USD 7.3 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.2 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	17.70%	2033 Value Projection:	USD 7.3 Bn

An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response to the presence of a foreign substance, called an antigen. Antigens are a wide range of substances that include disease-causing organisms and toxic materials such as insect venom, bacteria, or viruses. An antibody cocktail is basically a combination or cocktail of two different antibodies. The rationale behind combining two antibodies in a cocktail approach is to minimize mutational viral escape.

Market Dynamics

The increasing adoption of inorganic strategies such as partnerships and agreements by key players in the market is expected to drive the market growth during the forecast period. For instance, in May 2021, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Cipla Inc., a multinational pharmaceutical company, entered into a strategic partnership by which F. Hoffmann-La Roche Ltd., will import its antibody cocktail (Casirivimab and Imdevimab) medication into India, where it will then be marketed and distributed by the Cipla's distribution network.

Moreover, in August 2020, F. Hoffmann-La Roche Ltd., a multinational healthcare company, and Regeneron Pharmaceuticals Inc., a biotechnology company, announced that they had agreed to develop, manufacture, and distribute REGN-COV2, Regeneron's investigational antiviral antibody cocktail, to people around the globe. This collaboration is expected to increase the supply of REGN-COV2 by at least three and a half times the current capacity, with the potential for even further expansion. As a part of this agreement, Regeneron will be responsible for distributing REGN-COV2 in the U.S. and Roche will distribute it outside the U.S., as a part of this agreement.

Key features of the study

This report provides an in-depth analysis of the global antibody cocktails market, and provides market size (US$ million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global antibody cocktails market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Cipla Inc., F. Hoffmann-La Roche Ltd, Regeneron Pharmaceuticals Inc., Zydus Cadila, AstraZeneca, Aridis Pharmaceuticals Inc., Immunome Inc., Celltrion Healthcare Co., Ltd., and Eli Lilly and Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global antibody cocktails market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global antibody cocktails market

Market Segmentation

By Type
- Monovalent Antibody
- Polyvalent Antibody
By Indication
- COVID-19
- Cancer
- HIV
- Others
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Cipla Inc.
- Hoffmann-La Roche Ltd
- Regeneron Pharmaceuticals Inc.
- Zydus Cadila
- AstraZeneca
- Aridis Pharmaceuticals Inc.
- Immunome Inc.
- Celltrion Healthcare Co.,Ltd.
- Eli Lilly and Company.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Pipeline Analysis
Regulatory Scenario
Reimbursement Scenario
Product Launches
PEST Analysis

4. Global Antibody Cocktails Market, By Type, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Monovalent antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Polyvalent antibody
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Antibody Cocktails Market, By Indication, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
COVID-19
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
HIV
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Antibody Cocktails Market, By Distribution Channel, 2026 - 2033, (USD Bn)

Overview
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021-2033
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Antibody Cocktails Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - UK
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021-2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021-2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Regeneron Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Aridis Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZene Immunome Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Celltrion Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies